T1	Participants 15 67	children with autism and serious behavioral problems
T2	Participants 301 373	children with autistic disorder who have serious behavioral disturbances
T3	Participants 692 718	children 5 to 17 years old
T4	Participants 930 1086	A total of 101 children (82 boys and 19 girls; mean [+/-SD] age, 8.8+/-2.7 years) were randomly assigned to receive risperidone (49 children) or placebo (52
T5	Participants 2184 2215	children with autistic disorder
